Isogenic cell lines are selectively reengineered human cells that are used as genetic models for a specific patient population. Isogenic cell lines genetically match normal human cell and are used in clinical research and development of novel therapeutic drugs. With genetic foundation, isogenic cell lines can model any disease.
Most commonly, it is used for cancer research and for understanding the impact of genotype on cellular phenotype. Isogenic cell lines are developed from parenteral cells through targeted genetic mutation. By doing so, the genetic nature of parenteral cell lines is retained in isogenic cell lines.
It gives a better understanding of the cellular biology of a pathological condition and helps in the development of novel therapeutics. While the only difference of isogenic cell lines from parenteral cell lines is protein expression that enables cell-based screening.
Cell-based screening is an advantage of isogenic cell lines as it allows identification of a specific therapeutic agent that targets interested gene. Isogenic cell lines are produced from CRISPR (clustered regularly interspaced short palindromic repeat) technology from single parent cell lines. This technology allows free gene modification and it prevents the expression of other genomic footprints.
Isogenic Cell Lines Market: Drivers and Restraints
Rising demand for isogenic cell lines in cancer research has fueled the growth of the market. Traditionally, human disease models are used for the development of novel therapeutics & clinical research. The rapid advancement of technologies (like human-induced pluripotent stem cell (hiPSC) technology) led to the development of cellular models for clinical research.
Technological advancements have completely replaced traditional human models with isogenic cell lines. Further, the recent development of the CRISPR system has enabled genome editing and used for altering genetic makeup. It increased the adoption of isogenic cell lines in clinical research.
Rising prevalence of cancer has boosted the isogenic cell lines market as mostly isogenic cell lines are used for cancer research. Apart from understanding cellular mutation of diseases, isogenic cell lines are also used to understand the pathogenesis of disease and led to the development of patient-specific medicines.
Along with these, genetic manipulation techniques facilitate the development of genetic therapies for unmet medical needs and it is expected to boost the growth of isogenic cell lines market. All these factors are expected to fuel the growth of isogenic cell lines market in near future.
The complexity of isogenic cell lines development has restrained the growth of the market. But, complexity has limited the impact on the isogenic cell lines market
Isogenic Cell Lines Market: Overview
The global market for isogenic cell lines is expected to register a significant growth rate over the forecast period on account of huge demand of isogenic cell lines in cancer research. Isogenic cell lines market has a presence of limited market players with a huge market share.
In order to gain market share, manufacturers mainly depend on innovation and led to the improvising the existing isogenic cell lines models. It is further boosted by technological advancements by leading manufacturers. The future of isogenic cell lines market is expected to remain the same throughout the forecast period due to huge demand for the development of novel cancer therapeutics.
Isogenic Cell Lines Market: Regional Outlook
Geographically, the global isogenic cell lines market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to account for the major share in the global isogenic cell lines market owing to increasing research initiatives.
The isogenic cell lines market in Europe is the second major shareholder due to increasing focus on developing cancer therapeutics to attain the competitive edge in the cancer market. The Asia Pacific excluding Japan & Latin America is expected to witness a faster growth rate than other regions due to increasing capital investments from international players.
Avail customized purchase options for your needs
Isogenic Cell Lines Market: Key Players
The global isogenic cell lines market is highly fragmented owing to the presence of a large number of limited manufacturers. Examples of some of the key players operating in the global Isogenic Cell Lines market are
- AMS Biotechnology
- Applied StemCell
- Horizon Discovery Group plc
- Crown Bioscience Inc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers an exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
An Adaptive Approach to Modern-day Research Needs
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
- Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- APEJ (Greater China, India, S. Korea, ASEAN Countries and Rest of APEJ)
- Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)
- A detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Interested to Procure The Data
Isogenic Cell Lines Market: Segmentation
Tentatively, the global Isogenic Cell Lines market can be segmented on the basis of the end user, and geography.
Based on the end user, the global Isogenic Cell Lines market is segmented as:
- Biopharmaceutical Companies
- Research Organizations
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.